Global Neisseria meningitidis Infections Drug Market Research Report 2024

Report ID: 1977438 | Published Date: Jan 2025 | No. of Page: 97 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Neisseria meningitidis Infections Drug Market Overview
    1.1 Product Overview and Scope of Neisseria meningitidis Infections Drug
    1.2 Neisseria meningitidis Infections Drug Segment by Type
        1.2.1 Global Neisseria meningitidis Infections Drug Market Value Comparison by Type (2023-2029)
        1.2.2 MGBBP-3
        1.2.3 NCL-195
        1.2.4 TP-10
        1.2.5 Others
    1.3 Neisseria meningitidis Infections Drug Segment by Application
        1.3.1 Global Neisseria meningitidis Infections Drug Market Value by Application: (2023-2029)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Global Neisseria meningitidis Infections Drug Market Size Estimates and Forecasts
        1.4.1 Global Neisseria meningitidis Infections Drug Revenue 2018-2029
        1.4.2 Global Neisseria meningitidis Infections Drug Sales 2018-2029
        1.4.3 Global Neisseria meningitidis Infections Drug Market Average Price (2018-2029)
    1.5 Assumptions and Limitations
2 Neisseria meningitidis Infections Drug Market Competition by Manufacturers
    2.1 Global Neisseria meningitidis Infections Drug Sales Market Share by Manufacturers (2018-2023)
    2.2 Global Neisseria meningitidis Infections Drug Revenue Market Share by Manufacturers (2018-2023)
    2.3 Global Neisseria meningitidis Infections Drug Average Price by Manufacturers (2018-2023)
    2.4 Global Neisseria meningitidis Infections Drug Industry Ranking 2021 VS 2022 VS 2023
    2.5 Global Key Manufacturers of Neisseria meningitidis Infections Drug, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Neisseria meningitidis Infections Drug, Product Type & Application
    2.7 Neisseria meningitidis Infections Drug Market Competitive Situation and Trends
        2.7.1 Neisseria meningitidis Infections Drug Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Neisseria meningitidis Infections Drug Players Market Share by Revenue
        2.7.3 Global Neisseria meningitidis Infections Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neisseria meningitidis Infections Drug Retrospective Market Scenario by Region
    3.1 Global Neisseria meningitidis Infections Drug Market Size by Region: 2018 Versus 2022 Versus 2029
    3.2 Global Neisseria meningitidis Infections Drug Global Neisseria meningitidis Infections Drug Sales by Region: 2018-2029
        3.2.1 Global Neisseria meningitidis Infections Drug Sales by Region: 2018-2023
        3.2.2 Global Neisseria meningitidis Infections Drug Sales by Region: 2024-2029
    3.3 Global Neisseria meningitidis Infections Drug Global Neisseria meningitidis Infections Drug Revenue by Region: 2018-2029
        3.3.1 Global Neisseria meningitidis Infections Drug Revenue by Region: 2018-2023
        3.3.2 Global Neisseria meningitidis Infections Drug Revenue by Region: 2024-2029
    3.4 North America Neisseria meningitidis Infections Drug Market Facts & Figures by Country
        3.4.1 North America Neisseria meningitidis Infections Drug Market Size by Country: 2018 VS 2022 VS 2029
        3.4.2 North America Neisseria meningitidis Infections Drug Sales by Country (2018-2029)
        3.4.3 North America Neisseria meningitidis Infections Drug Revenue by Country (2018-2029)
        3.4.4 U.S.
        3.4.5 Canada
    3.5 Europe Neisseria meningitidis Infections Drug Market Facts & Figures by Country
        3.5.1 Europe Neisseria meningitidis Infections Drug Market Size by Country: 2018 VS 2022 VS 2029
        3.5.2 Europe Neisseria meningitidis Infections Drug Sales by Country (2018-2029)
        3.5.3 Europe Neisseria meningitidis Infections Drug Revenue by Country (2018-2029)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Neisseria meningitidis Infections Drug Market Facts & Figures by Country
        3.6.1 Asia Pacific Neisseria meningitidis Infections Drug Market Size by Country: 2018 VS 2022 VS 2029
        3.6.2 Asia Pacific Neisseria meningitidis Infections Drug Sales by Country (2018-2029)
        3.6.3 Asia Pacific Neisseria meningitidis Infections Drug Revenue by Country (2018-2029)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
        3.6.13 Philippines
    3.7 Latin America Neisseria meningitidis Infections Drug Market Facts & Figures by Country
        3.7.1 Latin America Neisseria meningitidis Infections Drug Market Size by Country: 2018 VS 2022 VS 2029
        3.7.2 Latin America Neisseria meningitidis Infections Drug Sales by Country (2018-2029)
        3.7.3 Latin America Neisseria meningitidis Infections Drug Revenue by Country (2018-2029)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Neisseria meningitidis Infections Drug Market Facts & Figures by Country
        3.8.1 Middle East and Africa Neisseria meningitidis Infections Drug Market Size by Country: 2018 VS 2022 VS 2029
        3.8.2 Middle East and Africa Neisseria meningitidis Infections Drug Sales by Country (2018-2029)
        3.8.3 Middle East and Africa Neisseria meningitidis Infections Drug Revenue by Country (2018-2029)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE
4 Segment by Type
    4.1 Global Neisseria meningitidis Infections Drug Sales by Type (2018-2029)
        4.1.1 Global Neisseria meningitidis Infections Drug Sales by Type (2018-2023)
        4.1.2 Global Neisseria meningitidis Infections Drug Sales by Type (2024-2029)
        4.1.3 Global Neisseria meningitidis Infections Drug Sales Market Share by Type (2018-2029)
    4.2 Global Neisseria meningitidis Infections Drug Revenue by Type (2018-2029)
        4.2.1 Global Neisseria meningitidis Infections Drug Revenue by Type (2018-2023)
        4.2.2 Global Neisseria meningitidis Infections Drug Revenue by Type (2024-2029)
        4.2.3 Global Neisseria meningitidis Infections Drug Revenue Market Share by Type (2018-2029)
    4.3 Global Neisseria meningitidis Infections Drug Price by Type (2018-2029)
5 Segment by Application
    5.1 Global Neisseria meningitidis Infections Drug Sales by Application (2018-2029)
        5.1.1 Global Neisseria meningitidis Infections Drug Sales by Application (2018-2023)
        5.1.2 Global Neisseria meningitidis Infections Drug Sales by Application (2024-2029)
        5.1.3 Global Neisseria meningitidis Infections Drug Sales Market Share by Application (2018-2029)
    5.2 Global Neisseria meningitidis Infections Drug Revenue by Application (2018-2029)
        5.2.1 Global Neisseria meningitidis Infections Drug Revenue by Application (2018-2023)
        5.2.2 Global Neisseria meningitidis Infections Drug Revenue by Application (2024-2029)
        5.2.3 Global Neisseria meningitidis Infections Drug Revenue Market Share by Application (2018-2029)
    5.3 Global Neisseria meningitidis Infections Drug Price by Application (2018-2029)
6 Key Companies Profiled
    6.1 Beijing Minhai Biotechnology Co Ltd
        6.1.1 Beijing Minhai Biotechnology Co Ltd Corporation Information
        6.1.2 Beijing Minhai Biotechnology Co Ltd Description and Business Overview
        6.1.3 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2023)
        6.1.4 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Product Portfolio
        6.1.5 Beijing Minhai Biotechnology Co Ltd Recent Developments/Updates
    6.2 Biological E Ltd
        6.2.1 Biological E Ltd Corporation Information
        6.2.2 Biological E Ltd Description and Business Overview
        6.2.3 Biological E Ltd Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2023)
        6.2.4 Biological E Ltd Neisseria meningitidis Infections Drug Product Portfolio
        6.2.5 Biological E Ltd Recent Developments/Updates
    6.3 China National Pharmaceutical Group Corp
        6.3.1 China National Pharmaceutical Group Corp Corporation Information
        6.3.2 China National Pharmaceutical Group Corp Description and Business Overview
        6.3.3 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2023)
        6.3.4 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Product Portfolio
        6.3.5 China National Pharmaceutical Group Corp Recent Developments/Updates
    6.4 GlaxoSmithKline Plc
        6.4.1 GlaxoSmithKline Plc Corporation Information
        6.4.2 GlaxoSmithKline Plc Description and Business Overview
        6.4.3 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Product Portfolio
        6.4.5 GlaxoSmithKline Plc Recent Developments/Updates
    6.5 Griffith University
        6.5.1 Griffith University Corporation Information
        6.5.2 Griffith University Description and Business Overview
        6.5.3 Griffith University Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2023)
        6.5.4 Griffith University Neisseria meningitidis Infections Drug Product Portfolio
        6.5.5 Griffith University Recent Developments/Updates
    6.6 ImmunoBiology Ltd
        6.6.1 ImmunoBiology Ltd Corporation Information
        6.6.2 ImmunoBiology Ltd Description and Business Overview
        6.6.3 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2023)
        6.6.4 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Product Portfolio
        6.6.5 ImmunoBiology Ltd Recent Developments/Updates
    6.7 JN-International Medical Corp
        6.6.1 JN-International Medical Corp Corporation Information
        6.6.2 JN-International Medical Corp Description and Business Overview
        6.6.3 JN-International Medical Corp Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 JN-International Medical Corp Neisseria meningitidis Infections Drug Product Portfolio
        6.7.5 JN-International Medical Corp Recent Developments/Updates
    6.8 MGB Biopharma Ltd
        6.8.1 MGB Biopharma Ltd Corporation Information
        6.8.2 MGB Biopharma Ltd Description and Business Overview
        6.8.3 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2023)
        6.8.4 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Product Portfolio
        6.8.5 MGB Biopharma Ltd Recent Developments/Updates
    6.9 Panacea Biotec Ltd
        6.9.1 Panacea Biotec Ltd Corporation Information
        6.9.2 Panacea Biotec Ltd Description and Business Overview
        6.9.3 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2023)
        6.9.4 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Product Portfolio
        6.9.5 Panacea Biotec Ltd Recent Developments/Updates
    6.10 Pfizer Inc
        6.10.1 Pfizer Inc Corporation Information
        6.10.2 Pfizer Inc Description and Business Overview
        6.10.3 Pfizer Inc Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2023)
        6.10.4 Pfizer Inc Neisseria meningitidis Infections Drug Product Portfolio
        6.10.5 Pfizer Inc Recent Developments/Updates
    6.11 Sanofi Pasteur SA
        6.11.1 Sanofi Pasteur SA Corporation Information
        6.11.2 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Description and Business Overview
        6.11.3 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2023)
        6.11.4 Sanofi Pasteur SA Neisseria meningitidis Infections Drug Product Portfolio
        6.11.5 Sanofi Pasteur SA Recent Developments/Updates
    6.12 Serum Institute of India Ltd
        6.12.1 Serum Institute of India Ltd Corporation Information
        6.12.2 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Description and Business Overview
        6.12.3 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2023)
        6.12.4 Serum Institute of India Ltd Neisseria meningitidis Infections Drug Product Portfolio
        6.12.5 Serum Institute of India Ltd Recent Developments/Updates
    6.13 Wellstat Vaccines LLC
        6.13.1 Wellstat Vaccines LLC Corporation Information
        6.13.2 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Description and Business Overview
        6.13.3 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Sales, Revenue and Gross Margin (2018-2023)
        6.13.4 Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Product Portfolio
        6.13.5 Wellstat Vaccines LLC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
    7.1 Neisseria meningitidis Infections Drug Industry Chain Analysis
    7.2 Neisseria meningitidis Infections Drug Key Raw Materials
       7.2.1 Key Raw Materials
       7.2.2 Raw Materials Key Suppliers
    7.3 Neisseria meningitidis Infections Drug Production Mode & Process
    7.4 Neisseria meningitidis Infections Drug Sales and Marketing
        7.4.1 Neisseria meningitidis Infections Drug Sales Channels
        7.4.2 Neisseria meningitidis Infections Drug Distributors
    7.5 Neisseria meningitidis Infections Drug Customers
8 Neisseria meningitidis Infections Drug Market Dynamics
    8.1 Neisseria meningitidis Infections Drug Industry Trends
    8.2 Neisseria meningitidis Infections Drug Market Drivers
    8.3 Neisseria meningitidis Infections Drug Market Challenges
    8.4 Neisseria meningitidis Infections Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

List of Tables
    Table 1. Global Neisseria meningitidis Infections Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Neisseria meningitidis Infections Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Neisseria meningitidis Infections Drug Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Neisseria meningitidis Infections Drug Sales (K Pcs) of Key Manufacturers (2018-2023)
    Table 5. Global Neisseria meningitidis Infections Drug Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Neisseria meningitidis Infections Drug Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Neisseria meningitidis Infections Drug Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Neisseria meningitidis Infections Drug Average Price (USD/Pcs) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Neisseria meningitidis Infections Drug, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Neisseria meningitidis Infections Drug, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Neisseria meningitidis Infections Drug, Product Type & Application
    Table 12. Global Key Manufacturers of Neisseria meningitidis Infections Drug, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Neisseria meningitidis Infections Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neisseria meningitidis Infections Drug as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Neisseria meningitidis Infections Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Neisseria meningitidis Infections Drug Sales by Region (2018-2023) & (K Pcs)
    Table 18. Global Neisseria meningitidis Infections Drug Sales Market Share by Region (2018-2023)
    Table 19. Global Neisseria meningitidis Infections Drug Sales by Region (2024-2029) & (K Pcs)
    Table 20. Global Neisseria meningitidis Infections Drug Sales Market Share by Region (2024-2029)
    Table 21. Global Neisseria meningitidis Infections Drug Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Neisseria meningitidis Infections Drug Revenue Market Share by Region (2018-2023)
    Table 23. Global Neisseria meningitidis Infections Drug Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Neisseria meningitidis Infections Drug Revenue Market Share by Region (2024-2029)
    Table 25. North America Neisseria meningitidis Infections Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Neisseria meningitidis Infections Drug Sales by Country (2018-2023) & (K Pcs)
    Table 27. North America Neisseria meningitidis Infections Drug Sales by Country (2024-2029) & (K Pcs)
    Table 28. North America Neisseria meningitidis Infections Drug Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Neisseria meningitidis Infections Drug Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Neisseria meningitidis Infections Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Neisseria meningitidis Infections Drug Sales by Country (2018-2023) & (K Pcs)
    Table 32. Europe Neisseria meningitidis Infections Drug Sales by Country (2024-2029) & (K Pcs)
    Table 33. Europe Neisseria meningitidis Infections Drug Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Neisseria meningitidis Infections Drug Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Neisseria meningitidis Infections Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Neisseria meningitidis Infections Drug Sales by Region (2018-2023) & (K Pcs)
    Table 37. Asia Pacific Neisseria meningitidis Infections Drug Sales by Region (2024-2029) & (K Pcs)
    Table 38. Asia Pacific Neisseria meningitidis Infections Drug Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Neisseria meningitidis Infections Drug Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Neisseria meningitidis Infections Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Neisseria meningitidis Infections Drug Sales by Country (2018-2023) & (K Pcs)
    Table 42. Latin America Neisseria meningitidis Infections Drug Sales by Country (2024-2029) & (K Pcs)
    Table 43. Latin America Neisseria meningitidis Infections Drug Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Neisseria meningitidis Infections Drug Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Neisseria meningitidis Infections Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Neisseria meningitidis Infections Drug Sales by Country (2018-2023) & (K Pcs)
    Table 47. Middle East & Africa Neisseria meningitidis Infections Drug Sales by Country (2024-2029) & (K Pcs)
    Table 48. Middle East & Africa Neisseria meningitidis Infections Drug Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Neisseria meningitidis Infections Drug Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Neisseria meningitidis Infections Drug Sales (K Pcs) by Type (2018-2023)
    Table 51. Global Neisseria meningitidis Infections Drug Sales (K Pcs) by Type (2024-2029)
    Table 52. Global Neisseria meningitidis Infections Drug Sales Market Share by Type (2018-2023)
    Table 53. Global Neisseria meningitidis Infections Drug Sales Market Share by Type (2024-2029)
    Table 54. Global Neisseria meningitidis Infections Drug Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Neisseria meningitidis Infections Drug Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Neisseria meningitidis Infections Drug Revenue Market Share by Type (2018-2023)
    Table 57. Global Neisseria meningitidis Infections Drug Revenue Market Share by Type (2024-2029)
    Table 58. Global Neisseria meningitidis Infections Drug Price (USD/Pcs) by Type (2018-2023)
    Table 59. Global Neisseria meningitidis Infections Drug Price (USD/Pcs) by Type (2024-2029)
    Table 60. Global Neisseria meningitidis Infections Drug Sales (K Pcs) by Application (2018-2023)
    Table 61. Global Neisseria meningitidis Infections Drug Sales (K Pcs) by Application (2024-2029)
    Table 62. Global Neisseria meningitidis Infections Drug Sales Market Share by Application (2018-2023)
    Table 63. Global Neisseria meningitidis Infections Drug Sales Market Share by Application (2024-2029)
    Table 64. Global Neisseria meningitidis Infections Drug Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Neisseria meningitidis Infections Drug Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Neisseria meningitidis Infections Drug Revenue Market Share by Application (2018-2023)
    Table 67. Global Neisseria meningitidis Infections Drug Revenue Market Share by Application (2024-2029)
    Table 68. Global Neisseria meningitidis Infections Drug Price (USD/Pcs) by Application (2018-2023)
    Table 69. Global Neisseria meningitidis Infections Drug Price (USD/Pcs) by Application (2024-2029)
    Table 70. Beijing Minhai Biotechnology Co Ltd Corporation Information
    Table 71. Beijing Minhai Biotechnology Co Ltd Description and Business Overview
    Table 72. Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 73. Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Product
    Table 74. Beijing Minhai Biotechnology Co Ltd Recent Developments/Updates
    Table 75. Biological E Ltd Corporation Information
    Table 76. Biological E Ltd Description and Business Overview
    Table 77. Biological E Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 78. Biological E Ltd Neisseria meningitidis Infections Drug Product
    Table 79. Biological E Ltd Recent Developments/Updates
    Table 80. China National Pharmaceutical Group Corp Corporation Information
    Table 81. China National Pharmaceutical Group Corp Description and Business Overview
    Table 82. China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 83. China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Product
    Table 84. China National Pharmaceutical Group Corp Recent Developments/Updates
    Table 85. GlaxoSmithKline Plc Corporation Information
    Table 86. GlaxoSmithKline Plc Description and Business Overview
    Table 87. GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 88. GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Product
    Table 89. GlaxoSmithKline Plc Recent Developments/Updates
    Table 90. Griffith University Corporation Information
    Table 91. Griffith University Description and Business Overview
    Table 92. Griffith University Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 93. Griffith University Neisseria meningitidis Infections Drug Product
    Table 94. Griffith University Recent Developments/Updates
    Table 95. ImmunoBiology Ltd Corporation Information
    Table 96. ImmunoBiology Ltd Description and Business Overview
    Table 97. ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 98. ImmunoBiology Ltd Neisseria meningitidis Infections Drug Product
    Table 99. ImmunoBiology Ltd Recent Developments/Updates
    Table 100. JN-International Medical Corp Corporation Information
    Table 101. JN-International Medical Corp Description and Business Overview
    Table 102. JN-International Medical Corp Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 103. JN-International Medical Corp Neisseria meningitidis Infections Drug Product
    Table 104. JN-International Medical Corp Recent Developments/Updates
    Table 105. MGB Biopharma Ltd Corporation Information
    Table 106. MGB Biopharma Ltd Description and Business Overview
    Table 107. MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 108. MGB Biopharma Ltd Neisseria meningitidis Infections Drug Product
    Table 109. MGB Biopharma Ltd Recent Developments/Updates
    Table 110. Panacea Biotec Ltd Corporation Information
    Table 111. Panacea Biotec Ltd Description and Business Overview
    Table 112. Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 113. Panacea Biotec Ltd Neisseria meningitidis Infections Drug Product
    Table 114. Panacea Biotec Ltd Recent Developments/Updates
    Table 115. Pfizer Inc Corporation Information
    Table 116. Pfizer Inc Description and Business Overview
    Table 117. Pfizer Inc Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 118. Pfizer Inc Neisseria meningitidis Infections Drug Product
    Table 119. Pfizer Inc Recent Developments/Updates
    Table 120. Sanofi Pasteur SA Corporation Information
    Table 121. Sanofi Pasteur SA Description and Business Overview
    Table 122. Sanofi Pasteur SA Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 123. Sanofi Pasteur SA Neisseria meningitidis Infections Drug Product
    Table 124. Sanofi Pasteur SA Recent Developments/Updates
    Table 125. Serum Institute of India Ltd Corporation Information
    Table 126. Serum Institute of India Ltd Description and Business Overview
    Table 127. Serum Institute of India Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 128. Serum Institute of India Ltd Neisseria meningitidis Infections Drug Product
    Table 129. Serum Institute of India Ltd Recent Developments/Updates
    Table 130. Wellstat Vaccines LLC Corporation Information
    Table 131. Wellstat Vaccines LLC Description and Business Overview
    Table 132. Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
    Table 133. Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Product
    Table 134. Wellstat Vaccines LLC Recent Developments/Updates
    Table 135. Key Raw Materials Lists
    Table 136. Raw Materials Key Suppliers Lists
    Table 137. Neisseria meningitidis Infections Drug Distributors List
    Table 138. Neisseria meningitidis Infections Drug Customers List
    Table 139. Neisseria meningitidis Infections Drug Market Trends
    Table 140. Neisseria meningitidis Infections Drug Market Drivers
    Table 141. Neisseria meningitidis Infections Drug Market Challenges
    Table 142. Neisseria meningitidis Infections Drug Market Restraints
    Table 143. Research Programs/Design for This Report
    Table 144. Key Data Information from Secondary Sources
    Table 145. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Neisseria meningitidis Infections Drug
    Figure 2. Global Neisseria meningitidis Infections Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Neisseria meningitidis Infections Drug Market Share by Type in 2022 & 2029
    Figure 4. MGBBP-3 Product Picture
    Figure 5. NCL-195 Product Picture
    Figure 6. TP-10 Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Neisseria meningitidis Infections Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 9. Global Neisseria meningitidis Infections Drug Market Share by Application in 2022 & 2029
    Figure 10. Hospital
    Figure 11. Clinic
    Figure 12. Others
    Figure 13. Global Neisseria meningitidis Infections Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 14. Global Neisseria meningitidis Infections Drug Market Size (2018-2029) & (US$ Million)
    Figure 15. Global Neisseria meningitidis Infections Drug Sales (2018-2029) & (K Pcs)
    Figure 16. Global Neisseria meningitidis Infections Drug Average Price (USD/Pcs) & (2018-2029)
    Figure 17. Neisseria meningitidis Infections Drug Report Years Considered
    Figure 18. Neisseria meningitidis Infections Drug Sales Share by Manufacturers in 2022
    Figure 19. Global Neisseria meningitidis Infections Drug Revenue Share by Manufacturers in 2022
    Figure 20. The Global 5 and 10 Largest Neisseria meningitidis Infections Drug Players: Market Share by Revenue in 2022
    Figure 21. Neisseria meningitidis Infections Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 22. Global Neisseria meningitidis Infections Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 23. North America Neisseria meningitidis Infections Drug Sales Market Share by Country (2018-2029)
    Figure 24. North America Neisseria meningitidis Infections Drug Revenue Market Share by Country (2018-2029)
    Figure 25. U.S. Neisseria meningitidis Infections Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 26. Canada Neisseria meningitidis Infections Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 27. Europe Neisseria meningitidis Infections Drug Sales Market Share by Country (2018-2029)
    Figure 28. Europe Neisseria meningitidis Infections Drug Revenue Market Share by Country (2018-2029)
    Figure 29. Germany Neisseria meningitidis Infections Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. France Neisseria meningitidis Infections Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. U.K. Neisseria meningitidis Infections Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Italy Neisseria meningitidis Infections Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Russia Neisseria meningitidis Infections Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 34. Asia Pacific Neisseria meningitidis Infections Drug Sales Market Share by Region (2018-2029)
    Figure 35. Asia Pacific Neisseria meningitidis Infections Drug Revenue Market Share by Region (2018-2029)
    Figure 36. China Neisseria meningitidis Infections Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. Japan Neisseria meningitidis Infections Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. South Korea Neisseria meningitidis Infections Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. India Neisseria meningitidis Infections Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Australia Neisseria meningitidis Infections Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Taiwan Neisseria meningitidis Infections Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Indonesia Neisseria meningitidis Infections Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Thailand Neisseria meningitidis Infections Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Malaysia Neisseria meningitidis Infections Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Philippines Neisseria meningitidis Infections Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Latin America Neisseria meningitidis Infections Drug Sales Market Share by Country (2018-2029)
    Figure 47. Latin America Neisseria meningitidis Infections Drug Revenue Market Share by Country (2018-2029)
    Figure 48. Mexico Neisseria meningitidis Infections Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Brazil Neisseria meningitidis Infections Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Argentina Neisseria meningitidis Infections Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Middle East & Africa Neisseria meningitidis Infections Drug Sales Market Share by Country (2018-2029)
    Figure 52. Middle East & Africa Neisseria meningitidis Infections Drug Revenue Market Share by Country (2018-2029)
    Figure 53. Turkey Neisseria meningitidis Infections Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 54. Saudi Arabia Neisseria meningitidis Infections Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 55. UAE Neisseria meningitidis Infections Drug Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 56. Global Sales Market Share of Neisseria meningitidis Infections Drug by Type (2018-2029)
    Figure 57. Global Revenue Market Share of Neisseria meningitidis Infections Drug by Type (2018-2029)
    Figure 58. Global Neisseria meningitidis Infections Drug Price (USD/Pcs) by Type (2018-2029)
    Figure 59. Global Sales Market Share of Neisseria meningitidis Infections Drug by Application (2018-2029)
    Figure 60. Global Revenue Market Share of Neisseria meningitidis Infections Drug by Application (2018-2029)
    Figure 61. Global Neisseria meningitidis Infections Drug Price (USD/Pcs) by Application (2018-2029)
    Figure 62. Neisseria meningitidis Infections Drug Value Chain
    Figure 63. Neisseria meningitidis Infections Drug Production Process
    Figure 64. Channels of Distribution (Direct Vs Distribution)
    Figure 65. Distributors Profiles
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Beijing Minhai Biotechnology Co Ltd
Biological E Ltd
China National Pharmaceutical Group Corp
GlaxoSmithKline Plc
Griffith University
ImmunoBiology Ltd
JN-International Medical Corp
MGB Biopharma Ltd
Panacea Biotec Ltd
Pfizer Inc
Sanofi Pasteur SA
Serum Institute of India Ltd
Wellstat Vaccines LLC
Frequently Asked Questions
Neisseria meningitidis Infections Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Neisseria meningitidis Infections Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Neisseria meningitidis Infections Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

CMTS & QAM

This report aims to provide a comprehensive presentation of the global market for CMTS & QAM, wit ... Read More